When evaluating the market, you want to pay attention to unusual activity (good or bad), and the non-stop recovery by the market during the past two weeks strikes us as unusually bullish—eight times out of 10 the market will stall out during the rally, but so far, there’s been a vacuum of selling pressures. That doesn’t mean everything is rosy (many divergences have popped up, and the number of stocks hitting new highs is much smaller than it was in January), but the persistent snapback is enough to put our Market Monitor back into a lean-bullish stance. And that means you should do some buying in some newly-powerful stocks.
This week’s list has a bunch of newer names that are mostly on the growth side of the fence. Our Top Pick is Demandware (DWRE), a small company with a big story. It’s thinly traded, so be sure to keep your position smaller than normal.

Stock Name	Price	Buy Range	Loss Limit
YY Inc. (YY)	0.00	63-66	56-58
Tesla, Inc. (TSLA)	818.87	190-195	165-170
SolarCity (SCTY)	0.00	70-75	63-64
Proofpoint (PFPT)	113.79	37.5-40.5	34-34.5
Monster Beverage Corporation (MNST)	0.00	70-71.5	62-64
Jones Lang LaSalle (JLL)	0.00	114-119	104-106
Intercept Pharmaceuticals (ICPT)	0.00	300-340	250-260
E*Trade Financial (ETFC)	0.00	21-22	19-19.5
Demandware (DWRE)	0.00	68-70	59-60
Athenahealth (ATHN)	0.00	180-187	160-162

The fact that the major indexes and, especially, a ton of growth stocks bounced sharply late last week is a bullish sign; it at least tells you buyers are still interested, especially when it comes to some fast-growing names that recently reported outstanding results. That said, we can’t conclude the market is off to the races again—all the major indexes (save the Nasdaq) are still below their 50-day lines, the number of stocks hitting new highs is still tiny, and much of the broad market has taken on lots of water. Some new buying is fine, as is holding your top performers, but be sure to hold some cash until the market confirms a new uptrend.

This week’s list has a bunch of stocks that are acting bullishly, including a few that recently gapped up on earnings. Our Top Pick is Michael Kors (KORS), a well-sponsored name that reported a blowout quarter last week. Try to buy on dips.

Stock Name	Price	Buy Range	Loss Limit
Yelp (YELP)	41.30	86-92	75-76
Valeant Pharmaceuticals (VRX)	0.00	133-138	124-125
USG Corp. (USG)	0.00	31-33	29.5-30
Salix Pharmaceuticals (SLXP)	0.00	95-99	89-90
ServiceNow (NOW)	341.86	63-65	57-58
Michael Kors Holdings Limited (KORS)	73.22	91-96	83-84
Incyte Corporation (INCY)	76.98	62.5-65	54-55
Keurig Green Mountain (GMCR)	0.00	102-107	89-90
Tableau Software (DATA)	126.42	84-88	78-80
Canadian Solar (CSIQ)	0.00	36.5-38.5	32-33

Last week’s market action provided an awesome opportunity to discover leading stocks; they were the ones that quickly bounced back from the broad market selling and broke out to new highs! It’s not often you get such a clear opportunity to separate the wheat from the chaff, but when you do, it’s worth taking advantage of. Today, all those stocks that broke out are on our favored list, while those that bounced weakly are suspect. And those that did worse? They should be sold—note that our Hold list on page 12 has shrunk a bit. Also arguing for selling is the fact that our Market Monitor remains in neutral territory, mainly because the market’s intermediate-term trend is down. In short, holding some cash and keeping new buys small is advised. Our favorite stock in today’s crop is WebMD (WBMD), which has solid growth prospects and a great technical set-up.

Stock Name	Price	Buy Range	Loss Limit
WebMD Health Corp. (WBMD)	0.00	44-46	39-40
Twitter (TWTR)	40.37	60-65	54-55
Sangamo BioSciences (SGMO)	0.00	16.5-18.5	14-15
Royal Caribbean Cruises (RCL)	0.00	47-50	45-46
Qihoo 360 (QIHU)	0.00	95-98	84-85
Pandora Media Inc. (P)	0.00	33-36	30-31
NPS Pharmaceuticals (NPSP)	0.00	32-35	29-30
Keryx Biopharmaceuticals (KERX)	0.00	14-15.5	12.5-13.5
Facebook, Inc. (FB)	0.00	60-62.5	55-56
Concur Technologies (CNQR)	0.00	113-115	100-102

The big news today is that last week’s market weakness turned our intermediate-term market-timing indicator negative. But no one indicator is perfect, and at Cabot, we use another indicator to measure the market’s long-term trend—and that indicator is still positive. Thus it’s a standoff, which means our Market Monitor is positioned at dead neutral. Short-term, we tend to think the market is ripe for more of a pullback, simply because it’s had such a great, long advance. But long-term, we remain optimistic that once the correction is complete, the main uptrend can continue, and this thinking, in part, is because there are so few investment alternatives! In any event, our goal is to continue presenting you with stock that are most prone to short-term strength, and this issue brings a nice mix of old and new. Read them all, choose your favorite story, and work to find a good entry point. Our favorite this week is Twitter (TWTR), which has a huge fundamental story and a decent technical setup.

Stock Name	Price	Buy Range	Loss Limit
Valeant Pharmaceuticals (VRX)	0.00	125-131	123-124
VeriSign (VRSN)	190.71	58.5-60.5	56-57
Vipshop Holdings (VIPS)	14.25	91-95	80-82
Twitter (TWTR)	40.37	56-62	52-53
Insulet (PODD)	175.69	41-43	39-40
Pandora Media Inc. (P)	0.00	31-33	29-29.5
Medivation (MDVN)	0.00	70-75	69-70
The Hain Celestial Group, Inc. (HAIN)	0.00	91-93	83-85
Gilead Sciences (GILD)	75.10	76-79	73-74
CalAmp (CAMP)	0.00	27-29	24-25

The evidence has generally improved during the past two weeks, with the major indexes remaining in solid uptrends and, most encouragingly, more growth-oriented stocks showing power and emerging from basing structures. All of that is to the good, but earnings season is ramping up, and we know that can change any stock’s or sector’s outlook in a hurry. Put it together, and we’re still sticking with our lean bullish stance—now’s probably not the time to buy five or six stocks at once, but there are many attractive names out there, and getting in at opportune times should pay off.

This week’s list is heavy on growth stocks, though there are a couple of cyclical and special situation ideas, too. Our favorite of the week is HomeAway (AWAY), a firm we remain keen on, and a stock that’s testing support for the first time since a powerful November breakout.

Stock Name	Price	Buy Range	Loss Limit
T-Mobile US (TMUS)	0.00	30-32	27-28
SolarCity (SCTY)	0.00	70-74	63-64
Altisource Residential (RESI)	0.00	31.5-33	29-29.5
Pacira Biosiences (PCRX)	54.85	63-65	53-55
Palo Alto Networks (PANW)	236.92	60-62.5	55-56
The Manitowoc Company (MTW)	0.00	23.5-25	21.5-22
Harman International Industries, Inc. (HAR)	0.00	87-90	80-81
Forest Labs (FRX)	0.00	65-70	59-60
HomeAway, Inc. (AWAY)	0.00	40-42	37-37.5
AOL, Inc. (AOL)	0.00	48-50	44-45

We’ve seen mixed action since the year began, which isn’t totally surprising given January’s normal wiggles. The major indexes are churning a bit up near their highs, something that can lead to short-term selling; at the very least, it’s telling you that buying pressures have eased as the calendar has flipped. On the other hand, we’re encouraged to see some growth stocks that had been sitting out the dance since early October begin to reassert themselves—so far this year, we’ve seen a handful of breakouts from legitimate bases, the first collection of breakouts since November, and most held well even in today’s selloff. All told, we continue to lean bullish, though we’re watching things closely.

This week’s list has a bunch of promising names, including a few with terrific growth stories. Our favorite of the week is Arris Group (ARRS), which, thanks to a huge acquisition last year, is a leading provider of next-generation set-top boxes. Try to buy on weakness.

Stock Name	Price	Buy Range	Loss Limit
Yelp (YELP)	41.30	74-78	69-70
United Therapeutics (UTHR)	0.00	105-110	95-97
United Continental Holdings (UAL)	96.76	43-45	39-40
Splunk (SPLK)	207.67	72-74	64-65
Pandora Media Inc. (P)	0.00	31.5-33.5	29-29.5
Medivation (MDVN)	0.00	68-70	63-64
JinkoSolar Holding (JKS)	0.00	31-34	28-29
FireEye (FEYE)	0.00	53-57	47-48
Broadcom Limited (AVGO)	266.26	50-52	47-48
Arris Group (ARRS)	0.00	23-24.5	20-21

The evidence has gotten a bit worse during the past week, with more misses than hits among leading growth stocks, and with the major indexes sagging a few days in a row. That said, early January is often tricky, with lots of crosscurrents, profit taking, repositioning and so on, so we’re hesitant to change our stance for the moment unless we see a decisive show of strength or weakness. The good news is that we are seeing more proper set-ups from many names that rested during the past six to 10 weeks; if a bunch of them emerge, it would give us some newer, fresher leadership to sink our teeth into.

This week’s list includes a bunch of smaller and less-well-known ideas, which we view as a good thing; most of the “obvious” stocks are either chopping around or suffering through some selling. Our Top Pick this week is YY Inc. (YY), which has had a huge run, but isn’t overly pricey and just surged out of a multi-week tight area. It’s very volatile but the potential is big.

Stock Name	Price	Buy Range	Loss Limit
YY Inc. (YY)	0.00	54-58	49-50
WisdomTree (WETF)	0.00	16-17	14.5-15
Western Digital Corporation (WDC)	0.00	80-83	75-76
Workday (WDAY)	194.88	81.5-85.5	77-78
Spirit AeroSystems (SPR)	92.54	32.5-34	30.5-31
NPS Pharmaceuticals (NPSP)	0.00	30.5-32	26-27
Jazz Pharmaceuticals (JAZZ)	0.00	120-127	112-113
Himax Technologies (HIMX)	0.00	12.5-14	11.5-12
E-House Holdings (EJ)	0.00	13.5-14.5	11-12
Canadian Solar (CSIQ)	0.00	33-35	28-29

It’s been a fun and fruitful 2013, and we hope you were able to snag a few winners this year. That said, while we enjoy reviewing this past year as much as anyone, our focus is on the present and the future—so far, the overall market is in fine shape, though intriguingly, despite what is supposed to be a quiet time of year, we’ve seen a few sharp selloffs among growth stocks during the past couple of days. Of course, there are always lots of crosscurrents at year-end, but it’s imperative to keep your eyes open, pick your spots on the buy side and have some stops in place should the selling spread. Right now, though, we’re sticking with our lean bullish stance and will see how things shake out when the calendar turns.
This week’s list is very diversified, with many different industries represented. Our favorite of the week is Salix Pharmaceuticals (SLXP), a solid growth firm whose recent buyout of Santarus could be a gamechanger.

Stock Name	Price	Buy Range	Loss Limit
United States Steel Corporation (X)	0.00	28-30	26-26.5
Valero Energy (VLO)	97.40	46-47	42-43
United Therapeutics (UTHR)	0.00	105-112	97-100
Seagate Technology (STX)	0.00	53-55	49-50
Salix Pharmaceuticals (SLXP)	0.00	86-90	81-82
Royal Caribbean Cruises (RCL)	0.00	45-47	39-40
NXP Semiconductors (NXPI)	0.00	43-45	40-41
Legg Mason Inc. (LM)	37.44	40-42	38-39
Facebook, Inc. (FB)	0.00	52.5-55.5	48-49
Conn’s Inc. (CONN)	0.00	74-78	68.5-69.5

The sellers did some damage last week, with many major indexes falling close to their 50-day moving averages. Today’s bounce obviously helps the situation, but even before today, many growth stocks were holding up well, with a few shooting ahead, despite the market’s troubles. Few stocks are running away on the upside, so we’re content to keep our Market Monitor just outside of bullish territory. But the action is another piece of evidence that growth stocks might finally be turning the corner.

This week’s list is a mixed bag of growth-ier ideas, but also some special situations. Our top pick is Forest Labs (FRX), a large company whose stock is enjoying increased institutional support. The current pullback offers a decent entry point.

Stock Name	Price	Buy Range	Loss Limit
United Rentals, Inc. (URI)	0.00	70-72	64-65
SouFun (SFUN)	0.00	70-72	60-61
IntercontinentalExchange, Inc. (ICE)	0.00	210-220	188-190
Huntington Ingalls (HII)	0.00	78-82	74-75
Generac Holdings (GNRC)	86.60	50-52	47-48
Forest Labs (FRX)	0.00	53-55	48-49
DreamWorks (DWA)	0.00	31-33	28-29
Buffalo Wild Wings (BWLD)	0.00	137-143	129-131
Arris Group (ARRS)	0.00	20-21	17-18
Advance Auto Parts (AAP)	0.00	104-108	96-98

From the start of October through the tail end of November, growth stocks (and, more generally, high relative strength stocks) were the dog’s dinner, flailing around even as the major indexes advanced. Now, though, with many stocks having etched two-month launching pads, the tone has improved—money is slowly (emphasis on slowly) coming out of defensive names and into faster movers. A bit more improvement and we’ll shift our Market Monitor into bullish territory, but for now, we’ll stick with our general “lean bullish” stance.

Another good sign is that, in this week’s list, we see many stocks that have shown recent power and are trading relatively tightly, a good sign of accumulation. Our favorite of the week is Harman International (HAR), a well-situated audio firm with very solid sales and earnings growth. The stock looks like it’s at a good entry around here.

Stock Name	Price	Buy Range	Loss Limit
Perrigo (PRGO)	0.00	151-154	140-142
Las Vegas Sands Corp. (LVS)	0.00	74-77	68-69
Illumina Inc. (ILMN)	289.74	97-101	90-91
Harman International Industries, Inc. (HAR)	0.00	78-80	70-71
Financial Engines (FNGN)	0.00	65-68.5	59-60
Deckers Outdoor Corp. (DECK)	141.68	83-85	70-71
Conn’s Inc. (CONN)	0.00	69-73	63-64
Baidu (BIDU)	0.00	165-170	140-145
AOL, Inc. (AOL)	0.00	42.5-45	39-40
Ambarella (AMBA)	52.79	23-24.5	20.5-21.5

The market didn’t do all that much during the holiday-shortened week, so our overall stance is unchanged—we’re still leaning bullish but are also holding some cash and are more focused on being patient and buying stocks at lower-risk entries. That said, we have seen a (very) subtle shift during the past couple of weeks; some of the defensive-type names have stagnated, with growth and speculative stocks acting a bit better. It’s too early to conclude that a big shift has occurred, but it’s something to watch closely—a movement back into growth stocks would be very encouraging.

In the meantime, we’re looking for newer names that have shown excellent power of late. This week’s list is chock-full of them, and our Top Pick is Biogen Idec (BIIB), a big biotech firm with big earnings growth coming. The stock just gapped out of a multi-month zone on favorable news.

Stock Name	Price	Buy Range	Loss Limit
Workday (WDAY)	194.88	78.5-81.5	75-75.5
Johnson Controls International plc (JCI)	0.00	48-50	43-44
Gogo Inflight (GOGO)	0.00	27-30	22-23
First Solar (FSLR)	83.74	59-61	49-51
Fifth & Pacific (FNP)	0.00	30.5-32	27.5-28
New Oriental Education (EDU)	113.97	28.5-30	26-26.5
Dexcom (DXCM)	421.36	33-35	29-30
Canadian Solar (CSIQ)	0.00	29-30.5	23-24
Bitauto Holdings (BITA)	0.00	29.5-31	25-26
Biogen (BIIB)	0.00	285-295	267-268

Has there ever been anything as overvalued as SpaceX (SPCX)?

Elon Musk’s rocket and space-based internet company reported $18.7 billion in revenue in 2025. That’s less than half the revenue declining electronics store chain Best Buy (BBY, $41.7 billion) generated last year, less than International Paper Company (IP, $23.6 billion), and barely more than Casey’s General Stores (CASY, $17.6 billion). Those three companies have a combined market cap of roughly $67 billion. As of this writing, SpaceX has a market cap of $2.7 trillion. That’s more than the combined market cap of Walmart (WMT), JPMorgan (JPM) and Visa (V). Together, those three companies generated $847 billion in revenue last year.

Small caps continue to hold up well. The S&P 600 Small Cap Index is up modestly since last Thursday and is trading just below the fresh all-time highs it hit earlier this week. The group’s resilience stands out, especially against a backdrop of narrowing leadership and ongoing rotation beneath the market’s surface.

The main macro development this week was the Fed’s June meeting and Chair Kevin Warsh’s press conference, which confirmed a shift in policy direction.

WHAT TO DO NOW: The market’s bounce has been a good one, and the intermediate-term outlook remains bright. That said, near term, there are still some crosscurrents (rotation into the broad market, Dow outperforming the Nasdaq) that tell us growth stocks could throw us another curveball in the coming week or two. Overall, then, we’re mostly standing pat, but we’re going to add a half-sized stake in Guardant Health (GH) here, leaving us with a still-good-sized cash position of 37% or so. Details below.

Stocks started this week with a huge rally as the Iran ceasefire deal appears to be the real thing.

Of course, it’s been months of supposed peace deals falling apart. It’s hard to believe. I’m sure that fact is holding the market back somewhat. But this one is different for a couple of reasons.

Stocks are starting off this week with a huge rally as the U.S. and Iran have reached a ceasefire deal.

We’ve been here before. These peace deals have fallen apart several times. I’m sure that fact is holding the market back somewhat. But this one is different for a couple of reasons. First, it’s the furthest a peace deal has gotten with both sides agreeing and independent verification from Pakistan. Second, this is what a peace deal would look like at this point if it’s real and lasting.

[Note: The Cabot Turnaround Letter weekly update won’t be published next Friday, June 19, due to the market being closed for the Juneteenth holiday.]

Before we get into the main topic for today’s newsletter update, a quick note on the portfolio is in order. I’m continuing our “spring cleaning” effort that we began last week by trimming a couple more of our holdings, but I’m also adding a new position to take the place of the recent deletions.

After two near-record-setting months, stocks are encountering their first real turbulence since March. It’s no surprise.

While stocks go up an average of 10% a year, they rarely do so in a straight line. And after the S&P 500 rallied nearly 20% in April and May and the Nasdaq shot up nearly 30%, a pullback of some kind – or possibly even a true correction – was to be expected. It seems it’s happening all at once.

Stocks look set to enter the summer near all-time highs, but leadership has narrowed, volatility has ticked up, and there’s been renewed scrutiny on the AI trade and valuation concerns in some of the market’s biggest winners.

At the same time, the macro backdrop remains a mix of resilience and intermittent turbulence. While economic data continues to hold up, energy prices remain elevated due to the ongoing Iran conflict – which has no end in sight – keeping upward pressure on inflation and yields.

Tech, commodity, AI, and Explorer stocks struggled this week as concern over capital expenditures increased. Mideast tensions intensified and inflation numbers came in yesterday at their highest rate in over three years, fueled by rising energy costs. The combination of anticipated higher interest rates and rising bond yields impacted the price of precious metals, with gold sliding below $4,200 an ounce and silver falling below $64 an ounce.

Stocks look to enter summer near all-time highs, but leadership has narrowed and volatility has ticked up thanks to renewed scrutiny on the AI trade and open-ended questions about valuations in some of the hottest areas of the market.

There’s also been more focus on the evolving macro landscape, which features a resilient U.S. economy but stubbornly high energy prices due to the ongoing Iran conflict, and somewhat elevated yields. We’re now looking at a higher likelihood of a Fed rate hike, with the odds of a hike by December now well over 50%.

The high-flying AI stocks got crushed on Friday. But those stocks started this week higher. Where do we go from here?

The technology-heavy Nasdaq index fell 4% on Friday, and the S&P 500 fell for the week for the first time in 10 weeks. A couple of things spooked investors. The AI trade turned sour after Broadcom (AVGO) reported earnings that included slightly lower revenue projections for its AI chips than were expected. Also, a blowout jobs report strengthened the case for a Fed rate hike by the end of the year.

A major economic narrative that took shape in recent years was the decline and (presumptive) inevitable death of the so-called “petrodollar,” as a growing number of countries diversified their foreign exchange reserves away from the U.S. dollar and toward gold and alternative currencies like the Chinese yuan.

A few Cabot Options Trader subscribers have asked me about ways to protect gains in their portfolios, so I thought I would write to everyone with a couple of strategies using options to hedge your portfolio.

A subscriber recently asked me if I keep a journal of my trades. Many traders keep journals so they can look back at their trades and evaluate what they did right and what they did wrong.

Want to know how the big institutional investors use options? Here is an example of how one trader spent $132 million on three technology stocks.

Options trading has its own vernacular. To know how to do it, you need to know what every options term means. Here are some of the basics.

Our Cabot Top Ten Trader’s market timing system consists of two parts—one based on the action of three select, growth-oriented market indexes, and the other based on the action of the fast-moving stocks Cabot Top Ten features.